In summary, we successfully confirmed three proteins (Fabp3, NfL, and IL-10) as potentially informative biomarkers to complement established AD biomarkers (Aβ and tau) through a three-centered, North American, non-ADNI study. Here, IL10 is linked to Alzheimer disease.